A study aimed to evaluate the effectiveness of 18F-labeled anti-carcinoembryonic antigen (CEA) T84.66 diabody, a genetically engineered non-covalent dimer of scFv, for microPET imaging of colon cancer xenografts [179]. This evidence concerns the gene CEACAM5 and colonic neoplasm.